Drugs / Dexamethasone 8 mg
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT02861573 Background | Nov 2016 → Oct 2027 expected | castration-resistant prostate carcinoma | Merck Sharp & Dohme LLC | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dexamethasone 8 mg | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02861573 ↗ |